Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. 1982

M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann

Blood coagulation Factor Xa and activated protein C are both serine proteases derived from circulating, vitamin K-dependent precursors. They express, respectively, procoagulant and anticoagulant properties through Ca2+ and phospholipid-dependent interactions with coagulation Factor Va. The present studies were undertaken to determine whether Factor Xa and activated protein C interact independently or competitively with Factor Va. The interactions were assessed by examining the activated protein C-catalyzed inactivation of Factor Va in the absence and presence of Factor Xa at various concentrations. The results indicated that the two proteins compete for Factor Va and that Factor Xa protects Factor Va from inactivation by activated protein C. The ability of Factor Xa to protect Factor Va was observed either in the absence of a Factor Xa substrate or under conditions in which the complex of Factor Va and Factor Xa was engaged in the conversion of substrate (prethrombin 1) to thrombin.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D011486 Protein C A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005165 Factor V Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease. Coagulation Factor V,Proaccelerin,AC Globulin,Blood Coagulation Factor V,Factor 5,Factor Five,Factor Pi,Factor V, Coagulation
D005170 Factor X Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder. Autoprothrombin III,Coagulation Factor X,Stuart Factor,Stuart-Prower Factor,Blood Coagulation Factor X,Factor 10,Factor Ten,Stuart Prower Factor,Factor X, Coagulation
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
November 1984, The Journal of biological chemistry,
M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
August 1987, The Journal of biological chemistry,
M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
October 1988, The Journal of biological chemistry,
M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
January 2009, Thrombosis and haemostasis,
M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
February 2001, The Journal of biological chemistry,
M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
May 2012, BMC systems biology,
M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
November 2000, Biochemistry,
M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
March 1996, Blood,
M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
November 1995, The Journal of biological chemistry,
M E Nesheim, and W M Canfield, and W Kisiel, and K G Mann
December 1993, The Journal of biological chemistry,
Copied contents to your clipboard!